Skip to main content
. 2016 Mar;71(3):128–134. doi: 10.6061/clinics/2016(03)02

Table 4.

Comparison of variables between the less invasive surfactant administration success and failure groups.

LISA Failure N=13 LISA Success N=17 p (95% CI)
Gestational age (weeks), mean(SD) 27.4(1.61) 29.1(2.02) 0.02
Birth weight (grams), mean(SD) 992(387) 1108 (397) 0.263
Prenatal corticosteroids, n(%) 9(69.2) 13(76.5) 0.691
Intubation at delivery, n(%) 30.8 17.6 0.4
Age at procedure (hours), mean(SD) 8.4(9.6) 13.7(17.7) 0.7
FiO2 before procedure, mean(SD) 4.6(37.6) 21.6(46) 0.5
FiO2 reduction after surfactant (>20%), n(%) 6(46.2) 16(94.1) 0.003
PPI during instillation, n(%) 2(15.4) 1(5.9) 0.39
PDA, % 46 29.4 0.3
Total iMV (hours), mean(SD) 196.46(244) 9.18(18.7) 0.04
Pneumothorax, n(%) 2(15.4) 0 0.09
BPD (II-III), % 30.8 25.6 0.907

LISA: less invasive surfactant administration.

BPD: bronchopulmonary dysplasia; iMV: invasive mechanical ventilation; PPI: positive pressure inflations; SD: standard deviation.